Puma Biotechnology Inc (NASDAQ:PBYI)

5.68
Delayed Data
As of Oct 22
 -0.21 / -3.57%
Today’s Change
5.61
Today|||52-Week Range
14.14
-44.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$252.6M

Company Description

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Contact Information

Puma Biotechnology, Inc.
10880 Wilshire Boulevard
Los Angeles California 90024
P:(424) 248-6500
Investor Relations:
142424865002011

Employees

Shareholders

Other institutional62.21%
Mutual fund holders27.01%
Individual stakeholders23.73%

Top Executives

Alan H. AuerbachChairman, President, CEO & Secretary
Maximo F. NouguesChief Financial Officer
Jeffrey LudwigChief Commercial Officer
Mariann OhanesianSenior Director-Investor Relations
Douglas HuntSVP-Regulatory Affairs & Medical Writing